APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Embolic Microspheres

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biodegradable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025190 pages

Choose your research edition.

Industry ResearchBiodegradable Embolic Microspheres Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Embolic Microspheres Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Biodegradable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Embolic Microspheres Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Embolic Microspheres Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Biodegradable Embolic Microspheres market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biodegradable Embolic Microspheres include Varian, Jiangsu Hengrui Medicine, Terumo Corporation, Tepha, Teleflex, Promedics AG, Occlugel, Nippon Kayaku and Next Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biodegradable Embolic Microspheres market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biodegradable Embolic Microspheres and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biodegradable Embolic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Embolic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.

Biodegradable Embolic Microspheres Segment by Company

Varian

Jiangsu Hengrui Medicine

Terumo Corporation

Tepha

Teleflex

Promedics AG

Occlugel

Nippon Kayaku

Next Biomedical

Mermaid Medical

Merit Medical Systems

CeloNova BioSciences

BTG Corporate

Biosphere Medical

Biocompatibles

Angio Dynamics

ABK Biomedical

Biodegradable Embolic Microspheres Segment by Type

Visualization Type

Environmentally Responsive Type

Radioactive Type

Other

Biodegradable Embolic Microspheres Segment by Application

Research Institution

Hospitals And Clinics

Biodegradable Embolic Microspheres Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Embolic Microspheres.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biodegradable Embolic Microspheres market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biodegradable Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biodegradable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biodegradable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biodegradable Embolic Microspheres Industry Trends Table 2. Biodegradable Embolic Microspheres Industry Drivers Table 3. Biodegradable Embolic Microspheres Industry Opportunities and Challenges Table 4. Biodegradable Embolic Microspheres Industry Restraints Table 5. Global Biodegradable Embolic Microspheres Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biodegradable Embolic Microspheres Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biodegradable Embolic Microspheres Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Biodegradable Embolic Microspheres Sales Market Share by Manufacturers Table 9. Global Biodegradable Embolic Microspheres Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Biodegradable Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biodegradable Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biodegradable Embolic Microspheres Manufacturers, Product Type & Application Table 13. Global Biodegradable Embolic Microspheres Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biodegradable Embolic Microspheres by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Visualization Type Table 17. Major Manufacturers of Environmentally Responsive Type Table 18. Major Manufacturers of Radioactive Type Table 19. Major Manufacturers of Other Table 20. Global Biodegradable Embolic Microspheres Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Biodegradable Embolic Microspheres Sales by Type (2021-2026) & (Tons) Table 22. Global Biodegradable Embolic Microspheres Sales by Type (2027-2032) & (Tons) Table 23. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2021-2026) Table 24. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2027-2032) Table 25. Global Biodegradable Embolic Microspheres Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 26. Global Biodegradable Embolic Microspheres Revenue by Type (2021-2026) & (Tons) Table 27. Global Biodegradable Embolic Microspheres Revenue by Type (2027-2032) & (Tons) Table 28. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2021-2026) Table 29. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Research Institution Table 31. Major Manufacturers of Hospitals And Clinics Table 32. Global Biodegradable Embolic Microspheres Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Biodegradable Embolic Microspheres Sales by Application (2021-2026) & (Tons) Table 34. Global Biodegradable Embolic Microspheres Sales by Application (2027-2032) & (Tons) Table 35. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2021-2026) Table 36. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2027-2032) Table 37. Global Biodegradable Embolic Microspheres Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Biodegradable Embolic Microspheres Revenue by Application (2021-2026) & (Tons) Table 39. Global Biodegradable Embolic Microspheres Revenue by Application (2027-2032) & (Tons) Table 40. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2021-2026) Table 41. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2027-2032) Table 42. Global Biodegradable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Biodegradable Embolic Microspheres Sales by Region (2021-2026) & (Tons) Table 44. Global Biodegradable Embolic Microspheres Sales Market Share by Region (2021-2026) Table 45. Global Biodegradable Embolic Microspheres Sales Forecasted by Region (2027-2032) & (Tons) Table 46. Global Biodegradable Embolic Microspheres Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 48. North America Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 49. North America Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 50. Europe Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 51. Europe Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 52. Europe Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 53. Asia Pacific Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 55. Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 56. South America, Middle East and Africa Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. South America, Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 58. South America, Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 59. Global Biodegradable Embolic Microspheres Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Biodegradable Embolic Microspheres Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Biodegradable Embolic Microspheres Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Biodegradable Embolic Microspheres Revenue Market Share by Region (2021-2026) Table 63. Global Biodegradable Embolic Microspheres Revenue Market Share by Region (2027-2032) Table 64. Varian Company Information Table 65. Varian Business Overview Table 66. Varian Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Varian Biodegradable Embolic Microspheres Product Portfolio Table 68. Varian Recent Development Table 69. Jiangsu Hengrui Medicine Company Information Table 70. Jiangsu Hengrui Medicine Business Overview Table 71. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio Table 73. Jiangsu Hengrui Medicine Recent Development Table 74. Terumo Corporation Company Information Table 75. Terumo Corporation Business Overview Table 76. Terumo Corporation Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio Table 78. Terumo Corporation Recent Development Table 79. Tepha Company Information Table 80. Tepha Business Overview Table 81. Tepha Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Tepha Biodegradable Embolic Microspheres Product Portfolio Table 83. Tepha Recent Development Table 84. Teleflex Company Information Table 85. Teleflex Business Overview Table 86. Teleflex Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Teleflex Biodegradable Embolic Microspheres Product Portfolio Table 88. Teleflex Recent Development Table 89. Promedics AG Company Information Table 90. Promedics AG Business Overview Table 91. Promedics AG Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Promedics AG Biodegradable Embolic Microspheres Product Portfolio Table 93. Promedics AG Recent Development Table 94. Occlugel Company Information Table 95. Occlugel Business Overview Table 96. Occlugel Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Occlugel Biodegradable Embolic Microspheres Product Portfolio Table 98. Occlugel Recent Development Table 99. Nippon Kayaku Company Information Table 100. Nippon Kayaku Business Overview Table 101. Nippon Kayaku Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio Table 103. Nippon Kayaku Recent Development Table 104. Next Biomedical Company Information Table 105. Next Biomedical Business Overview Table 106. Next Biomedical Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Next Biomedical Biodegradable Embolic Microspheres Product Portfolio Table 108. Next Biomedical Recent Development Table 109. Mermaid Medical Company Information Table 110. Mermaid Medical Business Overview Table 111. Mermaid Medical Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio Table 113. Mermaid Medical Recent Development Table 114. Merit Medical Systems Company Information Table 115. Merit Medical Systems Business Overview Table 116. Merit Medical Systems Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio Table 118. Merit Medical Systems Recent Development Table 119. CeloNova BioSciences Company Information Table 120. CeloNova BioSciences Business Overview Table 121. CeloNova BioSciences Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio Table 123. CeloNova BioSciences Recent Development Table 124. BTG Corporate Company Information Table 125. BTG Corporate Business Overview Table 126. BTG Corporate Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. BTG Corporate Biodegradable Embolic Microspheres Product Portfolio Table 128. BTG Corporate Recent Development Table 129. Biosphere Medical Company Information Table 130. Biosphere Medical Business Overview Table 131. Biosphere Medical Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio Table 133. Biosphere Medical Recent Development Table 134. Biocompatibles Company Information Table 135. Biocompatibles Business Overview Table 136. Biocompatibles Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Biocompatibles Biodegradable Embolic Microspheres Product Portfolio Table 138. Biocompatibles Recent Development Table 139. Angio Dynamics Company Information Table 140. Angio Dynamics Business Overview Table 141. Angio Dynamics Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio Table 143. Angio Dynamics Recent Development Table 144. ABK Biomedical Company Information Table 145. ABK Biomedical Business Overview Table 146. ABK Biomedical Biodegradable Embolic Microspheres Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio Table 148. ABK Biomedical Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Biodegradable Embolic Microspheres Distributors List Table 152. Biodegradable Embolic Microspheres Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Biodegradable Embolic Microspheres Product Image Figure 2. Global Biodegradable Embolic Microspheres Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biodegradable Embolic Microspheres Market Size (2021-2032) & (US$ Million) Figure 4. Global Biodegradable Embolic Microspheres Sales (2021-2032) & (Tons) Figure 5. Global Biodegradable Embolic Microspheres Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Biodegradable Embolic Microspheres Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Visualization Type Image Figure 9. Environmentally Responsive Type Image Figure 10. Radioactive Type Image Figure 11. Other Image Figure 12. Global Biodegradable Embolic Microspheres Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Biodegradable Embolic Microspheres Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2021-2032) Figure 15. Global Biodegradable Embolic Microspheres Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Biodegradable Embolic Microspheres Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2021-2032) Figure 18. Research Institution Image Figure 19. Hospitals And Clinics Image Figure 20. Global Biodegradable Embolic Microspheres Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Biodegradable Embolic Microspheres Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2021-2032) Figure 23. Global Biodegradable Embolic Microspheres Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Biodegradable Embolic Microspheres Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2021-2032) Figure 26. North America Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 27. North America Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 28. U.S. Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Canada Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Mexico Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 33. Germany Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 34. France Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 35. U.K. Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Italy Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Netherlands Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 40. China Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Japan Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 42. South Korea Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Southeast Asia Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 44. India Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Australia Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 48. Brazil Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South Africa Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Saudi Arabia Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Turkey Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Argentina Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 53. UAE Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Egypt Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Chile Biodegradable Embolic Microspheres Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Global Biodegradable Embolic Microspheres Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Biodegradable Embolic Microspheres Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Biodegradable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 59. North America Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Biodegradable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 61. Europe Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Biodegradable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Biodegradable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Biodegradable Embolic Microspheres Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Biodegradable Embolic Microspheres Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Visualization Type
  • Environmentally Responsive Type
  • Radioactive Type
  • Other
Applications
  • Research Institution
  • Hospitals And Clinics
Companies covered
  • Varian
  • Jiangsu Hengrui Medicine
  • Terumo Corporation
  • Tepha
  • Teleflex
  • Promedics AG
  • Occlugel
  • Nippon Kayaku
  • Next Biomedical
  • Mermaid Medical
  • Merit Medical Systems
  • CeloNova BioSciences
  • BTG Corporate
  • Biosphere Medical
  • Biocompatibles
  • Angio Dynamics
  • ABK Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biodegradable Embolic Microspheres Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biodegradable Embolic Microspheres Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biodegradable Embolic Microspheres Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biodegradable Embolic Microspheres Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biodegradable Embolic Microspheres Market Dynamics
  1. 2.1 Biodegradable Embolic Microspheres Industry Trends
  2. 2.2 Biodegradable Embolic Microspheres Industry Drivers
  3. 2.3 Biodegradable Embolic Microspheres Industry Opportunities and Challenges
  4. 2.4 Biodegradable Embolic Microspheres Industry Restraints
3 Biodegradable Embolic Microspheres Market by Manufacturers
  1. 3.1 Global Biodegradable Embolic Microspheres Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biodegradable Embolic Microspheres Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biodegradable Embolic Microspheres Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biodegradable Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biodegradable Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biodegradable Embolic Microspheres Manufacturers, Product Type & Application
  7. 3.7 Global Biodegradable Embolic Microspheres Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biodegradable Embolic Microspheres Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biodegradable Embolic Microspheres Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biodegradable Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 Biodegradable Embolic Microspheres Market by Type
  1. 4.1 Biodegradable Embolic Microspheres Type Introduction
  2. 4.1.1 Visualization Type
  3. 4.1.2 Environmentally Responsive Type
  4. 4.1.3 Radioactive Type
  5. 4.1.4 Other
  6. 4.2 Global Biodegradable Embolic Microspheres Sales by Type
  7. 4.2.1 Global Biodegradable Embolic Microspheres Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biodegradable Embolic Microspheres Sales by Type (2021-2032)
  9. 4.2.3 Global Biodegradable Embolic Microspheres Sales Market Share by Type (2021-2032)
  10. 4.3 Global Biodegradable Embolic Microspheres Revenue by Type
  11. 4.3.1 Global Biodegradable Embolic Microspheres Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Biodegradable Embolic Microspheres Revenue by Type (2021-2032)
  13. 4.3.3 Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2021-2032)
5 Biodegradable Embolic Microspheres Market by Application
  1. 5.1 Biodegradable Embolic Microspheres Application Introduction
  2. 5.1.1 Research Institution
  3. 5.1.2 Hospitals And Clinics
  4. 5.2 Global Biodegradable Embolic Microspheres Sales by Application
  5. 5.2.1 Global Biodegradable Embolic Microspheres Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biodegradable Embolic Microspheres Sales by Application (2021-2032)
  7. 5.2.3 Global Biodegradable Embolic Microspheres Sales Market Share by Application (2021-2032)
  8. 5.3 Global Biodegradable Embolic Microspheres Revenue by Application
  9. 5.3.1 Global Biodegradable Embolic Microspheres Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Biodegradable Embolic Microspheres Revenue by Application (2021-2032)
  11. 5.3.3 Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2021-2032)
6 Global Biodegradable Embolic Microspheres Sales by Region
  1. 6.1 Global Biodegradable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biodegradable Embolic Microspheres Sales by Region (2021-2032)
  3. 6.2.1 Global Biodegradable Embolic Microspheres Sales by Region (2021-2026)
  4. 6.2.2 Global Biodegradable Embolic Microspheres Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biodegradable Embolic Microspheres Revenue by Region
  1. 7.1 Global Biodegradable Embolic Microspheres Revenue by Region
  2. 7.1.1 Global Biodegradable Embolic Microspheres Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biodegradable Embolic Microspheres Revenue by Region (2021-2026)
  4. 7.1.3 Global Biodegradable Embolic Microspheres Revenue by Region (2027-2032)
  5. 7.1.4 Global Biodegradable Embolic Microspheres Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biodegradable Embolic Microspheres Revenue (2021-2032)
  8. 7.2.2 North America Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biodegradable Embolic Microspheres Revenue (2021-2032)
  11. 7.3.2 Europe Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biodegradable Embolic Microspheres Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biodegradable Embolic Microspheres Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biodegradable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Varian
  2. 8.1.1 Varian Company Information
  3. 8.1.2 Varian Business Overview
  4. 8.1.3 Varian Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Varian Biodegradable Embolic Microspheres Product Portfolio
  6. 8.1.5 Varian Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine
  8. 8.2.1 Jiangsu Hengrui Medicine Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 8.3 Terumo Corporation
  14. 8.3.1 Terumo Corporation Company Information
  15. 8.3.2 Terumo Corporation Business Overview
  16. 8.3.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio
  18. 8.3.5 Terumo Corporation Recent Developments
  19. 8.4 Tepha
  20. 8.4.1 Tepha Company Information
  21. 8.4.2 Tepha Business Overview
  22. 8.4.3 Tepha Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tepha Biodegradable Embolic Microspheres Product Portfolio
  24. 8.4.5 Tepha Recent Developments
  25. 8.5 Teleflex
  26. 8.5.1 Teleflex Company Information
  27. 8.5.2 Teleflex Business Overview
  28. 8.5.3 Teleflex Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teleflex Biodegradable Embolic Microspheres Product Portfolio
  30. 8.5.5 Teleflex Recent Developments
  31. 8.6 Promedics AG
  32. 8.6.1 Promedics AG Company Information
  33. 8.6.2 Promedics AG Business Overview
  34. 8.6.3 Promedics AG Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Promedics AG Biodegradable Embolic Microspheres Product Portfolio
  36. 8.6.5 Promedics AG Recent Developments
  37. 8.7 Occlugel
  38. 8.7.1 Occlugel Company Information
  39. 8.7.2 Occlugel Business Overview
  40. 8.7.3 Occlugel Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Occlugel Biodegradable Embolic Microspheres Product Portfolio
  42. 8.7.5 Occlugel Recent Developments
  43. 8.8 Nippon Kayaku
  44. 8.8.1 Nippon Kayaku Company Information
  45. 8.8.2 Nippon Kayaku Business Overview
  46. 8.8.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio
  48. 8.8.5 Nippon Kayaku Recent Developments
  49. 8.9 Next Biomedical
  50. 8.9.1 Next Biomedical Company Information
  51. 8.9.2 Next Biomedical Business Overview
  52. 8.9.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Next Biomedical Biodegradable Embolic Microspheres Product Portfolio
  54. 8.9.5 Next Biomedical Recent Developments
  55. 8.10 Mermaid Medical
  56. 8.10.1 Mermaid Medical Company Information
  57. 8.10.2 Mermaid Medical Business Overview
  58. 8.10.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio
  60. 8.10.5 Mermaid Medical Recent Developments
  61. 8.11 Merit Medical Systems
  62. 8.11.1 Merit Medical Systems Company Information
  63. 8.11.2 Merit Medical Systems Business Overview
  64. 8.11.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio
  66. 8.11.5 Merit Medical Systems Recent Developments
  67. 8.12 CeloNova BioSciences
  68. 8.12.1 CeloNova BioSciences Company Information
  69. 8.12.2 CeloNova BioSciences Business Overview
  70. 8.12.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio
  72. 8.12.5 CeloNova BioSciences Recent Developments
  73. 8.13 BTG Corporate
  74. 8.13.1 BTG Corporate Company Information
  75. 8.13.2 BTG Corporate Business Overview
  76. 8.13.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BTG Corporate Biodegradable Embolic Microspheres Product Portfolio
  78. 8.13.5 BTG Corporate Recent Developments
  79. 8.14 Biosphere Medical
  80. 8.14.1 Biosphere Medical Company Information
  81. 8.14.2 Biosphere Medical Business Overview
  82. 8.14.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio
  84. 8.14.5 Biosphere Medical Recent Developments
  85. 8.15 Biocompatibles
  86. 8.15.1 Biocompatibles Company Information
  87. 8.15.2 Biocompatibles Business Overview
  88. 8.15.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biocompatibles Biodegradable Embolic Microspheres Product Portfolio
  90. 8.15.5 Biocompatibles Recent Developments
  91. 8.16 Angio Dynamics
  92. 8.16.1 Angio Dynamics Company Information
  93. 8.16.2 Angio Dynamics Business Overview
  94. 8.16.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio
  96. 8.16.5 Angio Dynamics Recent Developments
  97. 8.17 ABK Biomedical
  98. 8.17.1 ABK Biomedical Company Information
  99. 8.17.2 ABK Biomedical Business Overview
  100. 8.17.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio
  102. 8.17.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biodegradable Embolic Microspheres Value Chain Analysis
  2. 9.1.1 Biodegradable Embolic Microspheres Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biodegradable Embolic Microspheres Production Mode & Process
  6. 9.2 Biodegradable Embolic Microspheres Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biodegradable Embolic Microspheres Distributors
  9. 9.2.3 Biodegradable Embolic Microspheres Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst